Beta-cyclodextrin/polyamide-amine arborescence macromolecule/gold nano particle compound and preparation and application thereof
A technology of amine dendrimers and gold nanoparticles, which is applied in the field of nanocomposites and its preparation and application, to achieve the effects of reducing cytotoxicity, good biocompatibility, and improving biocompatibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Weigh 90.3mg of CDI and 63.2mg of β-CD and dissolve them in 5mL of DMSO, respectively, and stir the reaction for 6h. Then, 5 mL of DMSO solution in which 57.9 mg of the fifth-generation polyamidoamine dendrimer (G5PAMAM) was dissolved was added dropwise to the solution, and stirred at room temperature for 3 days. After the reaction, the reaction solution was transferred to a dialysis bag with a molecular weight cut-off of 8000-14000Da, dialyzed in phosphate (PBS) buffer solution for 1 day, then replaced with ultrapure water for dialysis for 2 days, and finally freeze-dried to obtain a white Powder product G5.NH 2 -β-CD. Then weigh 39.5mg of G5.NH 2 - β-CD was dissolved in 5 mL of ultrapure water, and 322.7 μL of 30 mg / mL chloroauric acid aqueous solution (HAuCl 4 4H 2 O), after continuing to stir for 30min, quickly add 445μL of 10mg / mL sodium borohydride (NaBH 4 ) ice solution to continue the reaction for 4h. Finally, the reaction solution was transferred to a dia...
Embodiment 2
[0044] G5PAMAM, AuDENPs prepared in Comparative Example 1 and AuDENPs-β-CD prepared by the method of Example 1 (marked as Q0, Q1 and Q2 respectively) were 0.25, 0.5, 1, 2, 3 according to the N / P ratio , 4 and 5, the siRNA was 1 μg / well to prepare complexes for gel retardation experiments. Prepare 1% eight-well agarose gel containing ethidium bromide (EB), add 5 μL of Marker control group to the first well of the agarose gel, and add the above-mentioned complex solution to the remaining 2-8 wells in sequence. Electrophoresis was carried out at 80V for 45min, and then photographed and analyzed at 312nm by an ultraviolet gel analysis system. The results showed that all carriers showed the ability to completely block siRNA when the N / P ratio was more than 2:1, and each carrier was resistant to Bcl-2siRNA (attached figure 1 ) is slightly weaker than that of VEGFsiRNA (attached figure 2 ), and under the same N / P ratio, Q2 has a stronger ability to compress and wrap siRNA than Q0...
Embodiment 3
[0046] G5PAMAM, AuDENPs prepared in Comparative Example 1 and AuDENPs-β-CD prepared by the method of Example 1 (marked as Q0, Q1 and Q2 respectively) were prepared under different N / P ratio conditions (2.5:1, 5: 1 and 10:1) respectively formed carrier / siRNA complexes with 5 μg siRNA through electrostatic interaction, incubated at room temperature for 15-30 min, and then added 1 mL of LPBS buffer. The hydrodynamic particle size and surface potential were characterized by a Malvern laser particle size analyzer (Malvern, MK, 633nm laser). The results showed that under the conditions of three experimental N / P ratios, the carrier was effective for Bcl-2siRNA (attached image 3 a) and VEGFsiRNA (attached image 3 b) The hydrodynamic particle size of the composites decreases with the increase of N / P ratio. And the carrier is against Bcl-2siRNA (attached Figure 4 a) and VEGFsiRNA (attached Figure 4 b) The overall change trend of the surface potential of the complexes is roughly ...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka-patsnap-com.libproxy1.nus.edu.sg/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com